A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder - Related Studies

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

This study has been completed.

Study NCT00001381. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bladder Neoplasms
		Carcinoma, Transitional Cell

2	Additional conditions recognized in this trial
		Carcinoma
		Urinary Bladder Neoplasms

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Urinary Bladder Diseases
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		suramin

5	More general drug interventions related to this trial
		Anthelmintics
		Anti-Infective Agents
		Antinematodal Agents
		Antineoplastic Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses
		Trypanocidal Agents

6	Sponsors listed in this trial
		National Cancer Institute (NCI)